Finance

Lists
NOX:ASX
Noxopharm Ltd
A$0.059
0.00%
(0.00) 1D
Oct 2, 2:38:30 PM GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NOX...
Mkt. cap
18.13M
Avg. vol.
86.58K
Volume
0.00
52-wk high
A$0.11
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
307.24M
No. of employees
1K
Mkt. cap
18.13M
Avg. vol.
86.58K
Volume
0.00
52-wk high
A$0.11
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
307.24M
No. of employees
1K
News stories
From web sources and news partners
About Noxopharm Ltd
CEOGisela Mautner
Employees1K
Founded2015
HeadquartersCastle Hill, New South Wales, Australia
SectorBiotechnology
Websitenoxopharm.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
865.44K
865.44K
-151.75K
-151.75K
Cost of goods sold
814.91K
814.91K
156.60K
156.60K
Cost of revenue
814.91K
814.91K
156.60K
156.60K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
694.28K
694.28K
756.98K
756.98K
Operating expense
694.72K
694.72K
766.42K
766.42K
Total operating expenses
1.51M
1.51M
923.02K
923.02K
Operating income
-644.20K
-644.20K
-1.07M
-1.07M
Other non operating income
-19.92K
-19.92K
-144.08K
-144.08K
EBT including unusual items
-920.72K
-920.72K
-1.31M
-1.31M
EBT excluding unusual items
-920.72K
-920.72K
-1.52M
-1.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-920.72K
-920.72K
-1.31M
-1.31M
Net profit margin
-106.39%
-106.39%
861.44%
861.44%
Earnings per share
-
-
-
-
Interest and investment income
1.70K
1.70K
9.26K
9.26K
Interest expense
-250.29K
-250.29K
-320.48K
-320.48K
Net interest expenses
-248.58K
-248.58K
-311.22K
-311.22K
Depreciation and amortization charges
440.00
440.00
432.00
432.00
EBITDA
-643.76K
-643.76K
-1.07M
-1.07M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps